BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1665231)

  • 1. [Circulating anti-neural antibodies, an indication of a subtype of small cell lung cancer?].
    Drlicek M; Liszka U; Grisold W; Mohn-Staudner A; Lintner F
    Pathologe; 1991 Nov; 12(6):311-5. PubMed ID: 1665231
    [No Abstract]   [Full Text] [Related]  

  • 2. Predominant downgaze ophthalmoparesis in anti-Hu encephalomyelitis.
    Schiff ND; Moore DF; Winterkorn JM
    J Neuroophthalmol; 1996 Dec; 16(4):302-3. PubMed ID: 8956170
    [No Abstract]   [Full Text] [Related]  

  • 3. [Circulating antineuronal antibodies--use of a paraneoplastic phenomenon as tumor marker in small cell bronchial carcinoma].
    Popp W; Drlicek M; Grisold W; Zwick H
    Prax Klin Pneumol; 1988 Aug; 42(8):665-7. PubMed ID: 2845382
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.
    Dalmau J; Furneaux HM; Gralla RJ; Kris MG; Posner JB
    Ann Neurol; 1990 May; 27(5):544-52. PubMed ID: 2163235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescent analysis of antibodies against neurons in the case of paraneoplastic syndrome.
    Geppert A; Zeromski J; Szczech J; Kozubski W
    Folia Neuropathol; 1999; 37(3):199-202. PubMed ID: 10581859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sensory neuronopathy in small cell cancer of the lung. Immunocytochemical study of 2 cases.
    Kida E; Barcikowska M; Joachimowicz-Jaskowiak E; Michalska T; Siekierzynska A; Walasik A; Roszkowski K; Figura-Chojak E
    Clin Neuropathol; 1994; 13(2):64-70. PubMed ID: 8205728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung.
    Luiz JE; Lee AG; Keltner JL; Thirkill CE; Lai EC
    J Neuroophthalmol; 1998 Sep; 18(3):178-81. PubMed ID: 9736201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
    Maddison P; Newsom-Davis J; Mills KR; Souhami RL
    Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
    Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung].
    Graus F; Elkon KB; Cordón-Cardó C; Posner JB
    Neurologia; 1986; 1(1):11-5. PubMed ID: 2856257
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paraneoplastic encephalomyelitis: value of anti-Hu antibody in its diagnosis].
    Pujol A; Graus F
    Med Clin (Barc); 1991 Nov; 97(19):733-4. PubMed ID: 1666166
    [No Abstract]   [Full Text] [Related]  

  • 14. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 15. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.
    Debourdeau P; Gligorov J; Zammit C
    N Engl J Med; 1999 Nov; 341(19):1475-6. PubMed ID: 10577104
    [No Abstract]   [Full Text] [Related]  

  • 16. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging in untreated patients with small cell lung cancer.
    Vrdoljak E; Mise K; Sapunar D; Rozga A; Marusic M
    Neoplasma; 2001; 48(2):154-6. PubMed ID: 11478698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines.
    Bazhin AV; Savchenko MS; Belousov EV; Jaques G; Philippov PP
    Lung Cancer; 2004 Sep; 45(3):299-305. PubMed ID: 15301870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.